Prenatal diagnosis of epidermolytic hyperkeratosis by direct gene sequencing.

Article Details

Citation

Rothnagel JA, Longley MA, Holder RA, Kuster W, Roop DR

Prenatal diagnosis of epidermolytic hyperkeratosis by direct gene sequencing.

J Invest Dermatol. 1994 Jan;102(1):13-6.

PubMed ID
7507150 [ View in PubMed
]
Abstract

Epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma) is an autosomal dominant skin disorder caused by defects in the suprabasal keratins. Recently, mutations in the keratins 1 and 10 have been identified in patients with this disease. In this study, direct gene sequencing was used to establish the prenatal diagnosis in 15-week gestation twins at risk for epidermolytic hyperkeratosis. Direct sequence analysis of genomic DNA from the affected father and from both chorionic villus samples revealed a tyrosine to asparagine mutation at position 14 within the highly conserved 1A alpha-helical segment of keratin 10. None of the unaffected family members that were analyzed exhibit this mutation nor have polymorphic variations been observed in the normal population at this position. This residue is invariant in all type I keratins sequenced to date and is also conserved in related intermediate filament proteins such as vimentin and lamin. Given this high degree of conservation it is probable that any mutation at this position is deleterious and will result in disease.

DrugBank Data that Cites this Article

Polypeptides
NameUniProt ID
Keratin, type I cytoskeletal 10P13645Details